• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US PFC SIGMARP CV TB/IN S4 15.0; SIGMA KNEE PRIMARY : KNEE TIBIAL INSERT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US PFC SIGMARP CV TB/IN S4 15.0; SIGMA KNEE PRIMARY : KNEE TIBIAL INSERT Back to Search Results
Model Number 96-2043
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Fall (1848); Hemorrhage/Blood Loss/Bleeding (1888); Pain (1994); Synovitis (2094); Joint Laxity (4526); Swelling/ Edema (4577)
Date of Event 05/18/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event or Problem Description
Subject id: 007-08360, study: dots.Clinical notification received for revision of left total knee to address instability date of implantation: (b)(6) 2013, date of revision: (b)(6) 2021, (left knee).Treatment: revision of the tibial insert component.
 
Event or Problem Description
On (b)(6)2013, the patient underwent bilateral knee arthroplasties to address osteoarthritis.The patella was resurfaced and depuy products were implanted bilaterally.There were no indicated intra-operative complications.On (b)(6) 2021, the patient underwent a left knee revision to address pain, swelling, and instability.The patient experienced a fall prior to experiencing instability.The surgeon indicated evidence of recurrent bleeds as there was hemosiderin stained synovitis which was resected.There was a little wear on the retained patella, but no delamination.There was meniscus around the patella that was excised.The tibial insert was the only product revised.The tibial insert, femoral component, and patellar component were retained.There were no indicated intra-operative complications.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.H10 additional narrative:  if information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Investigation summary no device associated with this report was received for examination.Depuy synthes considers the investigation closed at this time.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.Device history lot the product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A manufacturing records evaluation (mre) was not performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PFC SIGMARP CV TB/IN S4 15.0
Common Device Name
SIGMA KNEE PRIMARY : KNEE TIBIAL INSERT
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
MDR Report Key12010318
Report Number1818910-2021-12818
Device Sequence Number3304039
Product Code NJL
UDI-Device Identifier10603295240839
UDI-Public10603295240839
Combination Product (Y/N)N
Initial Reporter StateCO
Initial Reporter CountryUS
PMA/510(K) Number
P830055
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2013
Device Explanted Year2021
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source health professional,study
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 06/03/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number96-2043
Device Catalogue Number962043
Device Lot Number3254406
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 06/03/2021
Supplement Date Received by Manufacturer06/15/2021
07/26/2021
Initial Report FDA Received Date06/16/2021
Supplement Report FDA Received Date07/15/2021
07/27/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
MBT CEM KEEL TIB TRAY SZ4; PFC SIGMA C/R NPOR FEM LT SZ 4; PFC SIGMA/OV/DOME PAT 3PEG,38
Outcome Attributed to Adverse Event Required Intervention;
Patient Age75 YR
Patient Weight91
-
-